The Food and Drug Administration recently approved a new low dose version of Orexo's treatment for opioid dependence. The drug, called Zubsolv, is a formulation of buprenorphine — a partial opioid ...

Buprenorphine is a partial opioid agonist, meaning it binds to the same opioid receptors in the brain as opiates like heroin or oxycodone. For people struggling with addiction, it reduces cravings as ...

Addressing overdoses from “street drugs” containing potent synthetic opioids poses a key challenge when utilizing opioid antagonists. A standard approach to known or suspected opioid overdose includes ...

Employing a nurse care manager to work with patients who have an opioid addiction and prescribing partial or full opioid agonists can help more people enter treatment in primary care settings, ...

Due to their small molecular size, opioids can cross the blood-brain barrier (BBB) to cause both the euphoria that makes such drugs so addictive and the adverse effects including the respiratory ...

Muse Treatment Alcohol & Drug Rehab Los Angeles has published a new educational resource that explains how opioid receptors ...